Dedicated to enhancing your practices’ daily processes for long-term success, 7connections is thrilled to announce an expansion in its services through its new partnership with US marketing giant, Infusionsoft.
Committed to increasing sales and marketing opportunities for small businesses, Infusionsoft combines everything your practice needs to promote itself successfully. With contact management, CRM, marketing automation and e-commerce all available in one single online system, it offers an easy, quick and cost-effective way to grow your business.
Lifecycle marketing plays a huge role in the growth and management of your patient-base, and so it will form an essential element to the services offered by 7connections and Infusionsoft. They will take you through all seven steps of the cycle, from attracting website traffic to capturing leads, nurturing prospects, converting prospects into sales, delivering customer satisfaction, upselling and acquiring business referrals. Each phase is as important as the next in order to not only attract new people to the practice, but to encourage them to become quality patients, and then keep them coming back.
Infusionsoft has already published some of the results it has achieved with small businesses, demonstrating a huge average increase in revenue of 400%![i] Enabling you to apply the theory to your specific business in a tangible way, 7connections and Infusionsoft will help you bring more patients through the door, while also reducing your costs. They will help you deliver a first-class experience to all existing and potential patients, use marketing automation in a personal way, enhance your patient communications and expand your business-to-business marketing for increased referrals, all helping your practice to truly thrive.
Working with 7connections and Infusionsoft you will not only discover the benefits of effective marketing, but you will also acquire new skills and tools to ensure you can move forward efficiently.
Watch this space for future innovative marketing solutions!
For more information about 7connections or the new partnership, call 01647 478145 or email This email address is being protected from spambots. You need JavaScript enabled to view it..
Alternatively, please visit the brand new website www.7connections.com.
By accepting you will be accessing a service provided by a third-party external to https://www.gdpuk.com/

GDPUK Ltd today announces the sale of its intellectual property assets to Cogora Group, one of the UK's leading publishers of healthcare brands, events and educational platforms.
The decision to sell GDPUK’s intellectual property forms part of a considered transition to ensure the long‑term stewardship and development of the brand and associated assets. Cogora brings a wealth of experience and expertise to support the continued evolution of the dentistry brand within its wide portfolio of market-leading healthcare publications. Its award-winning titles include Pulse, a long‑standing and widely recognised source of political news and clinical education for GPs, Nursing in Practice, Management in Practice, The Pharmacist, Pulse PCN and Healthcare Leader, as well as two secondary care publications – Hospital Healthcare Europe and Hospital Pharmacy Europe. The purchase will cement Cogora as the biggest publisher of primary care titles in the UK and allow it to bring its expertise in providing news, analysis, opinion and groundbreaking stories to GDPUK, as well as continue giving dentists and dental staff a voice through its website.
“After careful consideration, we believe that Cogora is well positioned to take GDPUK’s intellectual property forward,” said Tony Jacobs, founder, editor and publisher of GDPUK.com . “This transaction provides continuity for the professional community associated with GDPUK and creates opportunities for future growth under experienced ownership.”
Tony will continue involvement in GDPUK on a consulting basis.
GDPUK Ltd has worked to ensure an orderly transfer of the intellectual property and wishes Cogora every success in its future development.